RE:RE:Not sure I wanted to bring this topic up (again.)>> The issue I see with a low ball take out offer is that there are more than one big pharma watching here.
I strongly agree with that, which is why I think it would probably take at least $1.50/share, which would end up being around 1/2 billion (which is the figure I initially threw out here.) Even it were to spark another offer, I think anything around $2/share is still very cheap for big pharma to offer - and probably much, much lower than management at TLT would like to get for it. But, it's enough of an offer that I think that it would be a real challenge for Roger to defeat at this point.
So, to repeat... I'm inclined to think that anyone selling at these price levels is probably clueless as to the real potential of this stock to (otherwise unexpectedly) explode upwards the very near future as a result of what many here are suggesting is a "lowball offer."